NCT03314103View on ClinicalTrials.gov

Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

30,000

Participants

Timeline

Start Date

October 6, 2017

Primary Completion Date

January 19, 2019

Study Completion Date

January 19, 2019

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

One shot of the varicella-zoster virus vaccine

One shot of the live attenuated varicella-zoster virus vaccine (with live virus \>=4.3 LgPFU per dose)

BIOLOGICAL

one shot of placebo

one shot of placebo with no live virus

Trial Locations (3)

210009

Jiangsu Province Centers for Disease Control and Prevention, Nanjing

310051

Zhejiang Provincial Center for Disease Control and Prevention, Hanzhou

417000

Hunan Provincial Center for Disease Control and Prevention, Loudi

All Listed Sponsors
lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT03314103 - Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age | Biotech Hunter | Biotech Hunter